Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
55.45
+1.13 (+2.08%)
Official Closing Price
Updated: 4:10 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
65
66
Next >
Bristol Myers Squibb to Participate in the 2023 Jefferies London Healthcare Conference
November 09, 2023
From
Bristol Myers Squibb
Via
Business Wire
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture?
November 09, 2023
Via
Benzinga
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
November 09, 2023
From
Bristol Myers Squibb
Via
Business Wire
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity
October 30, 2023
Via
Benzinga
Is NYSE:BMY suited for dividend investing?
October 30, 2023
Is BRISTOL-MYERS SQUIBB CO (NYSE:BMY) suited for dividend investing?
Via
Chartmill
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Global Anal Cancer Market Size Expected to Reach $1.24 Billion In 2028 as Treatments Advance
November 09, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:BMY),(NASDAQ:GILD),(NYSE:MRK),(NYSE:PFE) EQNX::TICKER_END
Via
FinancialNewsMedia
3 No-Brainer Stocks to Buy With $500 Right Now
November 08, 2023
A reasonably modest amount of money can go a long way when it's invested in time-tested businesses with sustained catalysts.
Via
The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via
Benzinga
Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023
November 06, 2023
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb’s First Disclosures and New Data at ASH 2023 Highlight Company’s Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology
November 02, 2023
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb to Participate in the 2023 UBS BioPharma Conference
November 02, 2023
From
Bristol Myers Squibb
Via
Business Wire
Investor patience tested as pharmaceutical stocks take a tumble
November 01, 2023
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector
Via
MarketBeat
Christopher Boerner To Take The Helm At Bristol Myers Squibb As Chair Of The Board, CEO
October 31, 2023
Via
Benzinga
Bristol Myers Squibb Appoints Christopher Boerner, Ph.D., to Chair of the Board of Directors, Effective April 1, 2024
October 31, 2023
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes
October 30, 2023
From
Bristol Myers Squibb
Via
Business Wire
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
October 30, 2023
From
Bristol Myers Squibb
Via
Business Wire
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
October 28, 2023
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its...
Via
Talk Markets
Pharma Giant Bristol-Myers Stock At 52-Week Low: Analyst Sees Uncertainty In Near-Term Outlook
October 27, 2023
Bristol-Myers Squibb Co (NYSE: BMY) shares are trading lower on continuous weakness following the disappointing Q3 earnings and a downward revision to the
Via
Benzinga
Bristol Myers Squibb Analysts Slash Their Forecasts Following Q3 Results
October 27, 2023
Bristol Myers Squibb & Co (NYSE: BMY) reported better-than-expected earnings for its third quarter.
Via
Benzinga
Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review
October 27, 2023
Microsoft, Google, Amazon and Meta led big earnings.
Via
Investor's Business Daily
Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript
October 26, 2023
BMY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
US Stocks Mixed; Bristol Myers Posts Upbeat Earnings
October 26, 2023
U.S. stocks traded mixed this morning, following the release of several economic reports. Following the market opening Thursday, the Dow traded up 0.10% to 33,069.66 while the NASDAQ fell 0.24% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bristol Myers Squibb's Revlimid Sales Plunge 41%, but Opdivo and Eliquis Boost Q3, Stock Dips
October 26, 2023
Bristol Myers Squibb & Co (NYSE: BMY) said that its Q3 revenues of $10.966 billion declined 2% Y/Y, or 3% when adjusted for foreign exchange, due to lower sales of Revlimid, partially offset by in-line...
Via
Benzinga
Bristol Myers Skids 5% After Pushing Back A Key Sales Milestone By A Year
October 26, 2023
The company expects its new drugs to reach $10 billion in sales by 2026.
Via
Investor's Business Daily
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
October 26, 2023
Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in.
Via
Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
October 26, 2023
You won't have to worry about paying a premium for either one of these stocks -- and they both pay a solid dividend.
Via
The Motley Fool
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
October 26, 2023
From
Bristol Myers Squibb
Via
Business Wire
Meta, Amazon And 3 Stocks To Watch Heading Into Thursday
October 26, 2023
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fear Continues To Grip Markets As S&P 500 Settles Below 4,200
October 26, 2023
The CNN Money Fear and Greed index showed growth easing in the overall fear level, remaining in the "Fear" zone on Wednesday. U.S. stocks closed lower on Wednesday, with the S&P 500 closing the session...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
65
66
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.